Adam J Gordon — Publications

Cross-sectional Examination of Characteristics of Higher-Dose Buprenorphine Prescriptions During the Era of Illicit Fentanyl

2025
Association of Daily Doses of Buprenorphine With Urgent Health Care Utilization

2024
Associations Between State Policies Facilitating Telehealth and Buprenorphine Episode Initiation and Duration Early in the COVID Pandemic

2024
Growing Importance of High-Volume Buprenorphine Prescribers in OUD Treatment: 2009–2018

2024
Association of Selected State Policies and Requirements for Buprenorphine Treatment With Per Capita Months of Treatment

2023
Buprenorphine Treatment Episodes During the First Year of COVID: A Retrospective Examination of Treatment Initiation and Retention

2023
Differences in Medicaid Expansion Effects on Buprenorphine Treatment Utilization by County Rurality and Income: A Pharmacy Data Claims Analysis from 2009-2018

2023
Expert Views on State Policies to Improve Engagement and Retention in Treatment for Opioid Use Disorder: A Qualitative Analysis of an Online Modified Delphi Process

2023
Exploring the Association of State Policies and the Trajectories of Buprenorphine Prescriber Patient Caseloads

2023
National Trends in Buprenorphine Treatment for Opioid Use Disorder From 2007 to 2018

2023
Polydrug Use Among Patients on Methadone Medication Treatment: Evidence from Urine Drug Testing to Inform Patient Safety

2023
Prior Authorization Restrictions on Medications for Opioid Use Disorder: Trends in State Laws from 2005 to 2019

2023
Beyond State Scope of Practice Laws for Advanced Practitioners: Additional Supervision Requirements for Buprenorphine Prescribing

2022
Buprenorphine Treatment Episode Duration, Dosage, and Concurrent Prescribing of Benzodiazepines and Opioid Analgesics: The Effects of Medicaid Prior Authorization Policies

2022
Expert Panel Consensus on State-Level Policies to Improve Engagement and Retention in Treatment for Opioid Use Disorder

2022
Laws for Expanding Access to Medications for Opioid Use Disorder: A Legal Analysis of 16 States & Washington D.C.

2022
A National Survey of State Laws Regarding Medications for Opioid Use Disorder in Problem-Solving Courts

2022
Sociodemographic Differences in Quality of Treatment to Medicaid Enrollees Receiving Buprenorphine

2022
Subsequent Buprenorphine Treatment Following Emergency Physician Buprenorphine Prescription Fills: A National Assessment 2019 to 2020

2022
Buprenorphine Prescriber Monthly Patient Caseloads: An Examination of 6-Year Trajectories

2021
Common Themes in Early State Policy Responses to Substance Use Disorder Treatment During COVID-19

2021
Concentration of Patient Care Among Buprenorphine-Prescribing Clinicians in the U.S.

2021
Toward a Typology of Office-based Buprenorphine Treatment Laws: Themes from a Review of State Laws

2021
A Population-Based Examination of Trends and Disparities in Medication Treatment for Opioid Use Disorders Among Medicaid Enrollees

2018
Opioid Analgesic and Benzodiazepine Prescribing Among Medicaid-enrollees with Opioid Use Disorders: The Influence of Provider Communities

2016
Physician Capacity to Treat Opioid Use Disorder with Buprenorphine-Assisted Treatment

2016
Growth in Buprenorphine Waivers for Physicians Increased Potential Access to Opioid Agonist Treatment, 2002-11

2015
Policies Related to Opioid Agonist Therapy for Opioid Use Disorders: The Evolution of State Policies from 2004 to 2013

2015
Policies to Support a Better Treatment for Heroin and Prescription Opioid Abuse: Unlike Methadone, Buprenorphine Can Be Taken at Home, but Greater Access is Key

2015
Practice Guidance for Buprenorphine for the Treatment of Opioid Use Disorders: Results of an Expert Panel Process

2015
Supply of Buprenorphine Waivered Physicians: The Influence of State Policies

2015
Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties

2015
The Impact of Buprenorphine on Treatment of Opioid Dependence in a Medicaid Population: Recent Service Utilization Trends in the Use of Buprenorphine and Methadone

2012

U.S. research divisions

International research divisions

Adam J Gordon — Publications

Cross-sectional Examination of Characteristics of Higher-Dose Buprenorphine Prescriptions During the Era of Illicit Fentanyl

Association of Daily Doses of Buprenorphine With Urgent Health Care Utilization

Associations Between State Policies Facilitating Telehealth and Buprenorphine Episode Initiation and Duration Early in the COVID Pandemic

Growing Importance of High-Volume Buprenorphine Prescribers in OUD Treatment: 2009–2018

Association of Selected State Policies and Requirements for Buprenorphine Treatment With Per Capita Months of Treatment

Buprenorphine Treatment Episodes During the First Year of COVID: A Retrospective Examination of Treatment Initiation and Retention

Differences in Medicaid Expansion Effects on Buprenorphine Treatment Utilization by County Rurality and Income: A Pharmacy Data Claims Analysis from 2009-2018

Expert Views on State Policies to Improve Engagement and Retention in Treatment for Opioid Use Disorder: A Qualitative Analysis of an Online Modified Delphi Process

Exploring the Association of State Policies and the Trajectories of Buprenorphine Prescriber Patient Caseloads

National Trends in Buprenorphine Treatment for Opioid Use Disorder From 2007 to 2018

Polydrug Use Among Patients on Methadone Medication Treatment: Evidence from Urine Drug Testing to Inform Patient Safety

Prior Authorization Restrictions on Medications for Opioid Use Disorder: Trends in State Laws from 2005 to 2019

Beyond State Scope of Practice Laws for Advanced Practitioners: Additional Supervision Requirements for Buprenorphine Prescribing

Buprenorphine Treatment Episode Duration, Dosage, and Concurrent Prescribing of Benzodiazepines and Opioid Analgesics: The Effects of Medicaid Prior Authorization Policies

Expert Panel Consensus on State-Level Policies to Improve Engagement and Retention in Treatment for Opioid Use Disorder

Laws for Expanding Access to Medications for Opioid Use Disorder: A Legal Analysis of 16 States & Washington D.C.

A National Survey of State Laws Regarding Medications for Opioid Use Disorder in Problem-Solving Courts

Sociodemographic Differences in Quality of Treatment to Medicaid Enrollees Receiving Buprenorphine

Subsequent Buprenorphine Treatment Following Emergency Physician Buprenorphine Prescription Fills: A National Assessment 2019 to 2020

Buprenorphine Prescriber Monthly Patient Caseloads: An Examination of 6-Year Trajectories

Common Themes in Early State Policy Responses to Substance Use Disorder Treatment During COVID-19

Concentration of Patient Care Among Buprenorphine-Prescribing Clinicians in the U.S.

Toward a Typology of Office-based Buprenorphine Treatment Laws: Themes from a Review of State Laws

A Population-Based Examination of Trends and Disparities in Medication Treatment for Opioid Use Disorders Among Medicaid Enrollees

Opioid Analgesic and Benzodiazepine Prescribing Among Medicaid-enrollees with Opioid Use Disorders: The Influence of Provider Communities

Physician Capacity to Treat Opioid Use Disorder with Buprenorphine-Assisted Treatment

Growth in Buprenorphine Waivers for Physicians Increased Potential Access to Opioid Agonist Treatment, 2002-11

Policies Related to Opioid Agonist Therapy for Opioid Use Disorders: The Evolution of State Policies from 2004 to 2013

Policies to Support a Better Treatment for Heroin and Prescription Opioid Abuse: Unlike Methadone, Buprenorphine Can Be Taken at Home, but Greater Access is Key

Practice Guidance for Buprenorphine for the Treatment of Opioid Use Disorders: Results of an Expert Panel Process

Supply of Buprenorphine Waivered Physicians: The Influence of State Policies

Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties

The Impact of Buprenorphine on Treatment of Opioid Dependence in a Medicaid Population: Recent Service Utilization Trends in the Use of Buprenorphine and Methadone